Error
Jump to navigation
Jump to search
Pages in category "General Cardiology News"
The following 90 pages are in this category, out of 90 total.
C
G
H
- Heart failure: A1 Adenosine Antagonists for Heart Failure
- Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF
- Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management
- Heart Failure: Results of CORONA trial released
- Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007
- High Dose Diuretics Associated with Adverse Outcomes in ADHERE
- High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
I
- In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions
- Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease
- Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events.
- Inotrope-Dependent Heart Failure Patients Who Are Ineligible for Transplantation Benefit from Long-Term Mechanical Circulatory Support
- Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction
- Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial
- Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial
- Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD
- It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007
J
M
- Making the most of cardiac resynchronization therapy : remotely monitoring patients
- Metabolic syndrome linked to higher rates of atrial fibrillation
- Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome
- Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery
- Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI
- More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation
N
- Nephrotic syndrome and risk of venous and arterial thromboembolism
- New AHA statement focuses on improving rates and success of bystander CPR
- New AHA statement on hyperglycemia during ACS admissions
- New formula for predicting long-term survival based on exercise treadmill testing
- New guidelines for the management of cocaine chest pain
- New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant
- New study uses gene variants to predict cardiovascular risk
- New target for treating salt-induced hypertension
- NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial
P
- Panic Attacks in Postmenopausal Women Increase Risk of CV Events
- PCI: Nonclinical factors may influence physician decision-making
- Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial
- Planning your New Year’s resolution—which diet is best?
- Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis
- Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT
- Preoperative statins for prevention of atrial fibrillation following cardiac surgery
- Prevention: Results of the ILLUMINATE Trial Released at AHA 2007
- Promising results from a phase 2 study of a vaccine for hypertension
- PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication
- Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007
R
- Recombinant Human Erythropoietin (rHuEpo): Lack of Effect on Response to ASA or Clopidogrel
- Renin: who needs it, anyway?
- Results from STITCH Trial Demonstrate a Simplified, Step-Care Process is More Effective than Guidelines-Based Practice in Hypertension Treatment
- Rethinking a “healthy weight”: New study finds that being overweight is not associated with increased mortality from cardiovascular causes
- Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial
- Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality
- Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure
- Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS
- Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial
- Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial
S
- Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial
- SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up
- Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System
- Statins found to be protective against recurrence of atrial fibrillation after cardioversion
- Statins in Heart Failure: Results of CORONA
- Statins may cause sleep disorders
- Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
- Special:Badtitle/NS100:Study demonstrates that non-cardiac cells can help repair a damaged heart; new excitement for existence of cardiac stem cells. August 26, 2007
- Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity
- Susceptibility loci for intracranial aneurysm in European and Japanese populations
- SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
T
- Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial
- The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The safety of thiazolidinediones in older diabetics
- Special:Badtitle/NS100:Thyroid abnormalities affect more than 30% of males on amiodarone
- Tirofiban and transfer compares favorably to fibrinolysis in STEMI
- Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE
- TRANSCEND Study Misses Primary Endpoint
- TRANSCEND Study suggests that telmisartan reduces cardiovascular events
- Treatment of hypertension in the very old reduces all-cause mortality
- Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study
- Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism